Health Canada approves clinical trial for ToeFX Light Therapy Device
This announcement originally appeared on toefx.com. To read the original post click here.
ToeFX Inc., a Canadian medical device company developing a novel photodynamic therapy for onychomycosis, announced today that it has received Investigational Testing Approval (ITA) from Health Canada. Under the ITA, the company is authorized to begin clinical trials of the ToeFX Light Therapy device in Hamilton, Ontario. Trials are expected to begin in early 2020. The trial’s principal investigator is Dr. Alexander Rabinovich, MD, FRCSC, an orthopaedic surgeon and Assistant Clinical Professor (Adjunct) at McMaster University.
Patients may take the online screening questionnaire HERE